oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy
Upasana Sahu(The University of Texas Health Science Center at Houston), Balveen Kaur(Augusta University)
Cited by 12
Related Papers
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360
IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity
|Nature Communications|2025|11